Sector
Pharmaceuticals sector
14 companies in the Pharmaceuticals sector have financials on Smart Money, worth Rs 452.3 bn together at the latest close. Their latest annual reports add up to revenue of Rs 367.8 bn and profit of Rs 38.7 bn; 12 of the 14 were profitable. The median company trades at 12.3× earnings and 3.03× book value; the median dividend payer yields 4.7%. The largest is GlaxoSmithKline Pakistan Limited (GLAXO) at Rs 99.4 bn.
- Companies
- 14
- 12 profitable
- Market value
- Rs 452.3 bn
- at the close on 16 Oct 2026
- Median P/E
- 12.3×
- Median P/B 3.03×
- Median dividend yield
- 4.7%
- 8 dividend payers
- Median ROE
- 21.7%
- Median net margin 9.4%
Sector leaders
- Rs 99.4 bn
-
Rs 10.0 bn
Most profitable
GlaxoSmithKline Pakistan Limited GLAXO -
6.0%
Highest yield
Hoechst Pakistan Limited HPL -
9.5×
Lowest P/E
GlaxoSmithKline Pakistan Limited GLAXO -
50.9%
Highest ROE
Otsuka Pakistan Limited OTSU -
33.0%
Fastest growth (5-yr)
AGP Limited AGP
Sector revenue and profit
Sum of the companies reporting each fiscal year (fiscal years end in different months for different companies); years with fewer than half the sector reporting are left out.
Pharmaceuticals companies
Sorted by market value; select a column heading to sort.
| GLAXO | Rs 312.07 | Rs 99.4 bn | 9.5× | 2.89× | 5.4% | 32.4% | 7.7% | Rs 10.0 bn |
|---|---|---|---|---|---|---|---|---|
| ABOT | Rs 938.50 | Rs 91.9 bn | 10.7× | 2.86× | 4.3% | 28.8% | 10.6% | Rs 8.0 bn |
| HALEON | Rs 676.99 | Rs 79.2 bn | 12.0× | 4.88× | 4.4% | 47.6% | 15.9% | Rs 6.4 bn |
| HINOON | Rs 931.50 | Rs 49.4 bn | 12.5× | 3.83× | 5.4% | 32.3% | 12.4% | Rs 4.1 bn |
| AGP | Rs 162.48 | Rs 45.5 bn | 12.2× | 3.03× | 4.9% | 25.9% | 15.4% | Rs 3.7 bn |
| HPL | Rs 4,030.00 | Rs 38.9 bn | 10.4× | 4.55× | 6.0% | 38.6% | 15.7% | Rs 2.9 bn |
| FEROZ | Rs 333.00 | Rs 14.5 bn | 14.8× | 1.09× | 1.7% | 7.6% | 27.0% | Rs 978.6 mn |
| CPHL | Rs 62.11 | Rs 14.2 bn | 18.0× | 1.31× | 0.0% | 7.3% | 7.0% | Rs 790.3 mn |
| MACTER | Rs 245.90 | Rs 11.3 bn | 16.6× | 2.69× | 0.0% | 17.4% | 17.5% | Rs 679.4 mn |
| OTSU | Rs 376.00 | Rs 4.5 bn | 9.6× | 3.92× | 0.0% | 50.9% | 8.8% | Rs 472.1 mn |
| LIVEN | Rs 31.99 | Rs 3.6 bn | — | 3.67× | 0.0% | -3.8% | -16.9% | -Rs 31.1 mn |
| BFBIO | Rs 129.60 | — | — | — | 0.0% | 12.7% | — | — |
| IBLHL | Rs 41.50 | — | 18.5× | — | 0.0% | 9.1% | 6.6% | Rs 220.4 mn |
| SEARL | Rs 77.75 | — | 103.7× | — | 1.3% | 1.3% | 28.7% | Rs 440.4 mn |
Compare Pharmaceuticals companies
Pharmaceuticals sector: frequently asked questions
What is the P/E ratio of the Pharmaceuticals sector?
The median P/E of Pharmaceuticals companies on the Pakistan Stock Exchange is 12.3× at the latest close, counting only companies with positive earnings.
Which is the largest Pharmaceuticals company on PSX?
GlaxoSmithKline Pakistan Limited (GLAXO) is the largest by market value, at Rs 99.4 bn.
Which Pharmaceuticals stock has the highest dividend yield?
Hoechst Pakistan Limited (HPL) has the highest yield in the sector, 6.0%, based on its last annual dividend of Rs 240.00 per share and the latest close.
Which Pharmaceuticals company is the most profitable?
GlaxoSmithKline Pakistan Limited (GLAXO) reported the largest profit in its latest annual results, Rs 10.0 bn for FY2025.
How many Pharmaceuticals companies are listed on PSX?
Smart Money has financial statements for 14 Pharmaceuticals companies listed on the Pakistan Stock Exchange.
Information only, not investment advice.